|
DXCM | Dexcom Inc |
| Surgical & Medical Instruments & Apparatus |
| Book value per $ invested | $ 0.11 |
| Leverage | 56.69% |
| Market Cap | $ 25.2B |
| PE | 30.30 |
| Dividend Yield | 0.00% |
| Profit | $ 832.1m |
| Margin | 17.25% |
DexCom, Inc. is a company that develops, manufactures, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California, and has a manufacturing facility in Mesa, Arizona.